ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 308847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 308847; 2) Community: the network communities that were significantly associated with the response to NSC 308847; 3) Molecule: the relationships between components within communities and NSC 308847; 4) MDR: the compounds that were significantly associated with the NSC 308847.

NSC Compound Enrichment Correlation
NSC 132313 Dianhydrogalactitol 0.0238174255956147 0.53124905
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0238174255956147 0.28584526
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0238174255956147 0.43109681
NSC 300289 Pinafide 0.0238174255956147 0.41270835
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0238174255956147 0.47685571
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0238174255956147 0.50568187
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0238174255956147 0.34841975
NSC 45236 Null 0.0238174255956147 0.24520245
NSC 673787 Null 0.0238174255956147 -0.039789379
NSC 674182 Null 0.0238174255956147 0.45968902
Total:60  Current:26    [First] [Prev] [Next] [Last]